Translating efficacy into effectiveness in antiretroviral therapy: Beyond the pill count

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Durable and sustained suppression of HIV replication can be achieved as demonstrated in several recent clinical trials of antiretroviral (ARV) regimens. However, the efficacy demonstrated in the experimental setting does not always translate to effectiveness in the clinical setting. The frequency and number of medications (conventionally referred to as the pill count) contribute to regimen effectiveness. However, clinicians and HIV-infected patients recognise that there are several other characteristics of an ARV regimen that are equally important contributors to its effectiveness. Potency and durability, the potential for drug-drug interactions, and the occurrence of adverse events also contribute to the effectiveness and complexity of a drug regimen. A comprehensive consideration of factors associated with efficacy will optimise the translation to effectiveness for the individual infected with HIV.

Original languageEnglish (US)
Pages (from-to)1969-1979
Number of pages11
JournalDrugs
Volume67
Issue number14
DOIs
StatePublished - Jan 1 2007

Fingerprint

HIV
Drug interactions
Pharmaceutical Preparations
Durability
Drug Interactions
Therapeutics
Clinical Trials

Keywords

  • Antiretrovirals, therapeutic use
  • HIV infections, treatment
  • Lopinavir/ritonavir, therapeutic use

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Translating efficacy into effectiveness in antiretroviral therapy : Beyond the pill count. / Fletcher, Courtney V.

In: Drugs, Vol. 67, No. 14, 01.01.2007, p. 1969-1979.

Research output: Contribution to journalReview article

@article{a65103175be74a10976e24971fb92c65,
title = "Translating efficacy into effectiveness in antiretroviral therapy: Beyond the pill count",
abstract = "Durable and sustained suppression of HIV replication can be achieved as demonstrated in several recent clinical trials of antiretroviral (ARV) regimens. However, the efficacy demonstrated in the experimental setting does not always translate to effectiveness in the clinical setting. The frequency and number of medications (conventionally referred to as the pill count) contribute to regimen effectiveness. However, clinicians and HIV-infected patients recognise that there are several other characteristics of an ARV regimen that are equally important contributors to its effectiveness. Potency and durability, the potential for drug-drug interactions, and the occurrence of adverse events also contribute to the effectiveness and complexity of a drug regimen. A comprehensive consideration of factors associated with efficacy will optimise the translation to effectiveness for the individual infected with HIV.",
keywords = "Antiretrovirals, therapeutic use, HIV infections, treatment, Lopinavir/ritonavir, therapeutic use",
author = "Fletcher, {Courtney V.}",
year = "2007",
month = "1",
day = "1",
doi = "10.2165/00003495-200767140-00001",
language = "English (US)",
volume = "67",
pages = "1969--1979",
journal = "Drugs",
issn = "0012-6667",
publisher = "Adis International Ltd",
number = "14",

}

TY - JOUR

T1 - Translating efficacy into effectiveness in antiretroviral therapy

T2 - Beyond the pill count

AU - Fletcher, Courtney V.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Durable and sustained suppression of HIV replication can be achieved as demonstrated in several recent clinical trials of antiretroviral (ARV) regimens. However, the efficacy demonstrated in the experimental setting does not always translate to effectiveness in the clinical setting. The frequency and number of medications (conventionally referred to as the pill count) contribute to regimen effectiveness. However, clinicians and HIV-infected patients recognise that there are several other characteristics of an ARV regimen that are equally important contributors to its effectiveness. Potency and durability, the potential for drug-drug interactions, and the occurrence of adverse events also contribute to the effectiveness and complexity of a drug regimen. A comprehensive consideration of factors associated with efficacy will optimise the translation to effectiveness for the individual infected with HIV.

AB - Durable and sustained suppression of HIV replication can be achieved as demonstrated in several recent clinical trials of antiretroviral (ARV) regimens. However, the efficacy demonstrated in the experimental setting does not always translate to effectiveness in the clinical setting. The frequency and number of medications (conventionally referred to as the pill count) contribute to regimen effectiveness. However, clinicians and HIV-infected patients recognise that there are several other characteristics of an ARV regimen that are equally important contributors to its effectiveness. Potency and durability, the potential for drug-drug interactions, and the occurrence of adverse events also contribute to the effectiveness and complexity of a drug regimen. A comprehensive consideration of factors associated with efficacy will optimise the translation to effectiveness for the individual infected with HIV.

KW - Antiretrovirals, therapeutic use

KW - HIV infections, treatment

KW - Lopinavir/ritonavir, therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=34948875339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34948875339&partnerID=8YFLogxK

U2 - 10.2165/00003495-200767140-00001

DO - 10.2165/00003495-200767140-00001

M3 - Review article

C2 - 17883282

AN - SCOPUS:34948875339

VL - 67

SP - 1969

EP - 1979

JO - Drugs

JF - Drugs

SN - 0012-6667

IS - 14

ER -